会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Process for the synthesis of eneamide derivatives
    • 合成烯酰胺衍生物的方法
    • US07884243B2
    • 2011-02-08
    • US10583902
    • 2004-12-22
    • Alain BurgosBlandine BertrandSonia RoussiasseJean-François PluvieSylvie BlanchetJuliette MartinFlorence PerrinFrançoise Bourdeau
    • Alain BurgosBlandine BertrandSonia RoussiasseJean-François PluvieSylvie BlanchetJuliette MartinFlorence PerrinFrançoise Bourdeau
    • C07C233/00
    • C07C231/10C07C233/06C07C2602/08C07C2602/10
    • A process for the production of ene-amide derivatives represented by the formula (I) wherein R1 and R2 and R3 are independently a hydrogen atom, an alkyl, a cycloalkyl, a cycloalkylalkyl, an alkylaryl, an aryl, a heterocycle, a cyano, an alkoxy, an aryloxy, a carboxyl, a carbamoyl, —CONR5R6 (in which R5 and R6 are independently an alkyl, arylalkyl or aryl group said ring being substituted or not with a functional group or with R5) or —COOR5 group (in which R5 is an alkyl, alkylaryl or aryl group), said alkyl, cycloalkyl, cycloalkylalkyl, alkylaryl and aryl groups being substituted or not with a functional group or with R5; or R1 and R2 taken together, may form a ring (which terms includes mono-, di- and higher polycyclic ring systems); R4 is a hydrogen atom, an alkyl, an aryl, an alkylaryl, said groups are substituted or not with a halogen atom as Cl, Br, or F; X is an oxygen atom or a leaving group and m is an integer 1 or 2; when m is 1 then X is a leaving group; when m is 2 then X is a oxygen atom, which comprise: a hydrogenation/isomerization reaction in presence of a heterogeneous catalyst, of an oxime derivatives of formula (II) wherein R1, R2 and R3 are as defined above with an acyl derivative of formula (III) (R4CO)mX wherein R4, m and X are as defined above.
    • 制备由式(I)表示的烯 - 酰胺衍生物的方法,其中R 1和R 2和R 3独立地为氢原子,烷基,环烷基,环烷基烷基,烷基芳基,芳基,杂环,氰基, 烷氧基,芳氧基,羧基,氨基甲酰基-CONR 5 R 6(其中R 5和R 6独立地是烷基,芳基烷基或芳基,所述环被取代或不被官能团或与R5)或-COOR5基团(其中 R5是烷基,烷基芳基或芳基),所述烷基,环烷基,环烷基烷基,烷基芳基和芳基被官能团取代或不与R5取代; 或R 1和R 2一起形成环(该术语包括单环,二和更高多环系); R4是氢原子,烷基,芳基,烷基芳基,所述基团被卤素原子取代或未被取代为Cl,Br或F; X是氧原子或离去基团,m是整数1或2; 当m为1时,X为离去基团; 当m为2时,X为氧原子,其包括:在非均相催化剂存在下的氢化/异构化反应,式(II)的肟衍生物,其中R 1,R 2和R 3如上定义,与酰基衍生物 式(III)(R4CO)mX其中R4,m和X如上所定义。
    • 2. 发明申请
    • Process for the synthesis of eneamide derivatives
    • 合成烯酰胺衍生物的方法
    • US20070129573A1
    • 2007-06-07
    • US10583902
    • 2004-12-22
    • Alain BurgosBlandine BertrandSonia RoussiasseJean-Francois PluvieSylvie BlanchetJuliette MartinFlorence PerrinFrancoise Bourdeau
    • Alain BurgosBlandine BertrandSonia RoussiasseJean-Francois PluvieSylvie BlanchetJuliette MartinFlorence PerrinFrancoise Bourdeau
    • C07C233/06
    • C07C231/10C07C233/06C07C2602/08C07C2602/10
    • A process for the production of ene-amide derivatives represented by the formula (I) wherein R1 and R2 and R3 are independently a hydrogen atom, an alkyl, a cycloalkyl, a cycloalkylalkyl, an alkylaryl, an aryl, a heterocycle, a cyano, an alkoxy, an aryloxy, a carboxyl, a carbamoyl, —CONR5R6 (in which R5 and R6 are independently an alkyl, arylalkyl or aryl group said ring being substituted being substituted or not with a functional group or with R5) or —COOR5 group (in which R5 is an alkyl, alkylaryl or aryl group), said alkyl, cycloalkyl, cycloalkylalkyl, alkylaryl and aryl groups being substituted or not with a functional group or with R5; or R1 and R2 taken together, may form a ring (which terms includes mono-, di- and higher polycyclic ring systems); R4 is a hydrogen atom, an alkyl, an aryl, an alkylaryl, said groups substituted or not with a halogen atom as Cl, Br, or F; X is an oxygen atom or a leaving group and m is an integer 1 or 2; when m is 1 then X is a leaving group; when m is 2 then X is a oxygen atom, which comprise: a hydrogenation/isomerization reaction in presence of a heterogeneous catalyst, of an oxime derivatives of formula (II) where R1, R2 and R3 are as defined above with an acyl derivative of formula (III) (R4CO)mX wherein R4, m and X are as defined above.
    • 制备由式(I)表示的烯 - 酰胺衍生物的方法,其中R 1和R 2和R 3独立地为氢原子,烷基,环烷基,环烷基烷基,烷基芳基,芳基,杂环,氰基, 烷氧基,芳氧基,羧基,氨基甲酰基,-CONR 5 R 6(其中R 5和R 6独立地为所述被取代的环的烷基,芳基烷基或芳基被取代或不被官能团取代或与R5)或-COOR5基团 其中R5是烷基,烷基芳基或芳基),所述烷基,环烷基,环烷基烷基,烷基芳基和芳基被官能团取代或不与R5取代; 或R 1和R 2一起形成环(该术语包括单环,二和更高多环系统); R4是氢原子,烷基,芳基,烷基芳基,所述基团被卤素原子取代或不与Cl,Br或F取代; X是氧原子或离去基团,m是整数1或2; 当m为1时,X为离去基团; 当m为2时,X为氧原子,其包括:在非均相催化剂存在下的式(II)的肟衍生物,其中R 1,R 2和R 3如上所定义的肟衍生物与氢化/异构化反应,其中酰基衍生物为 式(III)(R4CO)m X其中R4,m和X如上定义。
    • 8. 发明授权
    • Optically active chiral diphosphine ligands
    • 光学活性的手性二膦配体
    • US06794525B2
    • 2004-09-21
    • US10356233
    • 2003-01-31
    • Michel BulliardBlandine LaboueSonia Roussiasse
    • Michel BulliardBlandine LaboueSonia Roussiasse
    • C07F1500
    • C07F15/0053B01J31/2409B01J31/2414B01J2231/52B01J2231/643B01J2231/645B01J2531/0208B01J2531/0266B01J2531/26B01J2531/31B01J2531/42B01J2531/46B01J2531/821B01J2531/822B01J2531/827C07B53/00C07B2200/07C07C67/31C07F9/5027C07C69/732
    • An (R) or (S) chiral diphosphine of formula (I): wherein R and R1, which can be identical or different, represent an optionally saturated C1-10 alkyl group, an optionally saturated C3-9 cycloalkyl group, a C5-10 aryl group, the groups being optionally substituted by a halogen, a hydroxy, a C1-5 alkoxy, an amino, a sulfino, a sulonfyl, with R4 representing an alkyl, an alkoxy or an alkylcarbonyl, the alkyl, cycloalkyl, aryl groups optionally including one or more heteroatoms, or R and R1 together represent an optionally saturated C2-6 substituted alkyl group, an optionally saturated C3-9 cycloalkyl group, a C5-10 aryl group, the cycloalkyl or aryl groups being optionally substituted by a C1-5 alkyl, a halogen, a hydroxy, a C1-5 alkoxy, an amino, a sulfino, a sulonfyl, with R4 representing an alkyl, an alkoxy or an alkylcarbonyl, the alkyl, cycloalkyl, aryl groups optionally including one or more heteroatoms, R2 and R3, which can be identical or different, represent an optionally saturated C3-8 cycloalkyl group, a C6-10 aryl group, the groups being optionally substituted by a halogen, a hydroxy, a C1-5 alkoxy, an amino, a sulfino, a sulonfyl, with R4 representing an alkyl, an alkoxy or an alkylcarbonyl, the cycloalkyl, aryl groups optionally including one or more heteroatoms, or R2 and R3 together form an optionally saturated C4-8 cyclic group, a C6-10 aryl group, the groups being optionally substituted by a halogen, a hydroxy, a C1-5 alkoxy, an amino, a sulfino, a sulonfyl, with R4 representing an alkyl, an alkoxy or an alkylcarbonyl, the cyclic and aryl groups optionally including one or more heteroatoms.
    • 式(I)的(R)或(S)手性二膦:其中R和R 1可以相同或不同,表示任选饱和的C 1-10烷基,任选饱和的C 3-9环烷基, 10芳基,该基团任选被卤素,羟基,C 1-5烷氧基,氨基,亚磺酰基,磺酰基取代,R 4表示烷基,烷氧基或烷基羰基,烷基,环烷基,芳基 任选地包括一个或多个杂原子,或R和R 1一起表示任选饱和的C 2-6取代烷基,任选饱和的C 3-9环烷基,C 5-10芳基,环烷基或芳基任选被C 1 -5-烷基,卤素,羟基,C 1-5烷氧基,氨基,亚磺酰基,磺酰基,其中R 4表示烷基,烷氧基或烷基羰基,烷基,环烷基,芳基,任选地包括一个或多个杂原子 可以相同或不同的R 2和R 3表示任选饱和的 C 3〜C 8环烷基,C 6-10芳基,所述基团任选被卤素,羟基,C 1-5烷氧基,氨基,亚磺酰基,磺酰基取代,R 4表示烷基,烷氧基或 烷基羰基,环烷基,任选地包括一个或多个杂原子的芳基,或者R 2和R 3一起形成任选饱和的C 4-8环基,C 6-10芳基,该基团任选被卤素取代,羟基, C 1-5烷氧基,氨基,亚磺酰基,磺酰基,其中R 4表示烷基,烷氧基或烷基羰基,环和芳基任选地包括一个或多个杂原子。